Z-scan analysis: a new method to determine the oxidative state of low-density lipoprotein and its association with multiple cardiometabolic biomarkers
MCP de Freitas, AM Figueiredo Neto… - Brazilian Journal of …, 2016 - Springer
The great atherogenic potential of oxidized low-density lipoprotein has been widely
described in the literature. The objective of this study was to investigate whether the state of …
described in the literature. The objective of this study was to investigate whether the state of …
[HTML][HTML] Effect of oxidation on the structure of human low-and high-density lipoproteins
CLP Oliveira, PR Santos, AM Monteiro, AMF Neto - Biophysical journal, 2014 - cell.com
This work presents a controlled study of low-density lipoprotein (LDL) and high-density
lipoprotein (HDL) structural changes due to in vitro oxidation with copper ions. The changes …
lipoprotein (HDL) structural changes due to in vitro oxidation with copper ions. The changes …
Correlation between lag time of ldl to in vitro oxidation and in vivo oxidized ldl in the patients with coronary artery disease
BACKGROUND: The oxidative modification of low density lipoprotein (LDL) is believed to
play an important role in the development of atherosclerosis. Thus, measurement of plasma …
play an important role in the development of atherosclerosis. Thus, measurement of plasma …
A simple method to assess the oxidative susceptibility of low density lipoproteins
AE Scoccia, MS Molinuevo, AD McCarthy… - BMC Clinical …, 2001 - Springer
Background Oxidative modification of low density lipoproteins (LDL) is recognized as one of
the major processes involved in atherogenesis. The in vitro standardized measurement of …
the major processes involved in atherogenesis. The in vitro standardized measurement of …
Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease
T Suzuki, H Kohno, A Hasegawa, S Toshima… - Clinical …, 2002 - Elsevier
Objectives: To examine the diagnostic performance of circulating oxidized low density
lipoprotein levels as a biochemical risk marker of coronary heart disease. Design and …
lipoprotein levels as a biochemical risk marker of coronary heart disease. Design and …
Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease
LE Schreier, S Sanguinetti, H Mosso, GI Lopez, L Siri… - Clinical …, 1996 - Elsevier
Objectives: To characterize low-density lipoprotein (LDL) chemical composition and
oxidability in normolipidemic and dyslipidemic patients with atherosclerotic cardiovascular …
oxidability in normolipidemic and dyslipidemic patients with atherosclerotic cardiovascular …
High oxidative stress in patients with stable coronary heart disease
T Weinbrenner, M Cladellas, MI Covas, M Fitó… - Atherosclerosis, 2003 - Elsevier
Oxidized low density lipoprotein (oxLDL) plays a pivotal role in the development of
atherosclerosis. The aim of the study was to investigate the relationship between oxLDL and …
atherosclerosis. The aim of the study was to investigate the relationship between oxLDL and …
A sensitive chemiluminescence imaging immunoassay for simultaneous detection of serum oxidized lipoprotein (a) and low density lipoprotein
R Yu, J Song, J Wu, D Niu, L Ma, C Zong… - Clinical Chemistry and …, 2014 - degruyter.com
Abstract Background: Oxidized lipoprotein (a)[ox-Lp (a)] and oxidized low density lipoprotein
(ox-LDL) levels have been reported to be useful predictors of cardiovascular events. The …
(ox-LDL) levels have been reported to be useful predictors of cardiovascular events. The …
Elastic modulus of low-density lipoprotein as potential indicator of its oxidation
S Takeda, A Subagyo, SP Hui, H Fuda… - Annals of Clinical …, 2015 - journals.sagepub.com
Background Evaluation of low-density lipoprotein oxidation is important in the risk
assessment of cardiovascular disease. Atomic force microscope is widely used to evaluate …
assessment of cardiovascular disease. Atomic force microscope is widely used to evaluate …
Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases
A Trpkovic, I Resanovic, J Stanimirovic… - Critical reviews in …, 2015 - Taylor & Francis
Atherosclerosis is a life-long illness that begins with risk factors, which in turn contribute to
the development of subclinical disease, followed by the establishment of overt …
the development of subclinical disease, followed by the establishment of overt …